Associated Papers
Prognostic significance of actionable next-generation sequencing multigene panel in esophageal cancer treatment.
Teke Z et al.
European Review for Medical and Pharmacological Sciences, 2024
Circulating Tumor DNA Analysis Detects FGFR2 Amplification and Concurrent Genomic Alterations Associated with FGFR Inhibitor Efficacy in Advanced Gastric Cancer.
Jogo T et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2021
34376535 (PubMed )
Supplement: 10780432ccr211414-sup-264192_2_supp_7269219_qwjmm7.pdf
A phase II study of poziotinib in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.
Lee JH et al.
Cancer Medicine, 2021
PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer.
Stein A et al.
Journal for Immunotherapy of Cancer, 2021
34315821 (PubMed )
Supplement: jitc-2021-002844supp002.xlsx › Supplementary_Table_S3
Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer.
Aggarwal C et al.
Jama Oncology, 2019
Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBL.
Tan YC et al.
Scientific Reports, 2017
Select a paper to view details